Abstract
This study compared the efficacy of buprenorphine to methadone for decreasing cocaine use in patients with combined opioid and cocaine use. Participants (n=51) were enrolled in a 26-week treatment program and randomly assigned to either buprenorphine or methadone. Dosing was double-blind and double-dummy. Patients were stabilized on either 8 mg sublingual buprenorphine or 50 mg oral methadone, with dose increases given in response to continued illicit cocaine use or opioid use through week 16 of treatment. Maximum doses possible were 16 mg buprenorphine and 90 mg methadone. Average doses achieved were 11.2 mg buprenorphine and 66.6 mg methadone; 49% of the patients received the maximum doses possible. Urine samples were collected three times per week, and there was no significant difference in the rate of cocaine positive urines for the intent-to-treat sample (69% for buprenorphine versus 63% for methadone). For patients who remained in treatment through the flexible dosing period (n=28), there were significant decreases in cocaine positive urines over time (P<0.01), but no significant differences between groups or group × time effects. Buprenorphine and methadone were equally effective on measures of treatment retention, urine results for opioids, and compliance with attendance and counseling. These results demonstrate no selective efficacy of either buprenorphine or methadone in attenuating cocaine use in this population, but do provide further support for the equivalent efficacy of buprenorphine and methadone in the treatment of opioid dependence.
Similar content being viewed by others
References
Ball JC, Ross A (1991) The effectiveness of methadone maintenance treatment. Springer, New York
Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE (1988) A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther 43:72–78
Brown EE, Finlay JM, Wong JTF, Damsam G, Fibiger HC (1991) Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 256:119–126
Condelli WS, Fairbank JA, Dennis ML, Rachal JV (1991) Cocaine use in clients in methadone programs: significance, scope and behavioral interventions. J Subst Abuse Treat 8:203–212
Crowley TJ, Williams EA, Mikulich SK, Ingersoll NC (1993) Buprenorphine and cocaine effects on social behavior of monkeys. Drug Alcohol Depend 31:235–245
Dykstra LA, Doty P, Johnson AB, Picker MJ (1992) Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drug Alcohol Depend 30:227–234
Gastfriend DR, Wapler M, Teoh SK, Reif S, Mendelson JH, Mello NK. (1993) Effects of buprenorphine on needle sharing, drug use and drug craving in men with combined heroin and cocaine dependence. In: Harris LS (ed) Problems of drug dependence 1992 (National Institute on Drug Abuse research monograph 132). Government Printing Office, Washington, DC, p 312
Johnson RE, Cone EJ, Henningfield JE, Fudala PJ (1989) Use of buprenorphine in the treatment of opioid addiction. I. Physiologic and behavioral effects during a rapid dose induction. Clin Pharmacol Ther 46:335–343
Johnson RE, Jaffe JH, Fudala PJ (1992) A controlled trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. JAMA 267: 2750–2755
Kosten TR, Kleber HD, Morgan C (1989a) Treatment of cocaine abuse with buprenorphine. Biol Psychiatry 26:637–639
Kosten TR, Kleber HD, Morgan C (1989b) Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 44:887–892
Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J (1993) Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis 181:358–364
McLellan AT, Luborsky L, Woody GE, O'Brien CP (1980) An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 168:26–33
Mello NK, Mendelson JH, Bree MP, Lukas SE (1989) Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science 245:859–862
Mello NK, Lukas SE, Kamien JB, Mendelson JH, Drieze J, Cone EJ (1992) The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther 260:1185–1193
Mello NK, Kamien JB, Lukas SE, Mendelson JH, Drieze J, Sholar JW (1993) Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 264:530–541
Mendelson JH, Teoh SK, Mello NK, Ellingboe J (1992) Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man. Neuropsychopharmacology 7:157–162
Rawson RA, Obert JL, McCann MJ, Castro FG, Ling W (1991) Cocaine abuse treatment: a review of current strategies. J Subst Abuse 3:457–491
Rosen MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR (1993) Effects of acute buprenorphine on responses to intranasal cocaine. In: Harris LS (ed) Problems of drug dependence 1992 (National Institute on Drug Abuse research monograph 132). Government Printing Office, Washington, DC, p 340
Spitzer RL, Williams JBW (1985) Structured clinical interview for DSM-III-R. New York State Psychiatric Institute, Biometrics Research, New York
Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1993) Dose-response effects of methadone in the treatment of opioid dependence. Ann Int Med 119:23–27
Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1994a) The effects of cocaine in buprenorphine maintained outpatient volunteers: Results from clinical experience and laboratory challenges. Am J Addict 3:129–143
Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1994b) Comparison of buprenorphine to methadone in the treatment of opioid dependence. Am J Psychiatry 151:1025–1030
Teoh SK, Sintavanarong P, Kuehnle J, Mendelson JH, Hallgring E, Rhoades E, Mello NK (1993) Buprenorphine's effects on morphine and cocaine challenges in heroin and cocaine dependent men. In: Harris LS (ed) Problems of drug dependence 1992 (National Institute on Drug Abuse research monograph 132). Government Printing Office, Washington, DC, p 460
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strain, E.C., Stitzer, M.L., Liebson, I.A. et al. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users. Psychopharmacology 116, 401–406 (1994). https://doi.org/10.1007/BF02247469
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02247469